0001520138-23-000269.txt : 20230626 0001520138-23-000269.hdr.sgml : 20230626 20230626160600 ACCESSION NUMBER: 0001520138-23-000269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DO CUONG V CENTRAL INDEX KEY: 0001477037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 231042395 MAIL ADDRESS: STREET 1: C/O BIOVIE STREET 2: 2120 COLORADO AVENUE, SUITE 230 CITY: SANTA MONICA STATE: CA ZIP: 90404 FORMER NAME: FORMER CONFORMED NAME: Do Cuong V DATE OF NAME CHANGE: 20091118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0407 4 2023-06-21 0 0001580149 BIOVIE INC. BIVI 0001477037 DO CUONG V C/O BIOVIE INC. 680 W NYE LANE STE 201 CARSON CITY NV 89703 1 1 0 0 CEO & President 0 Common Stock 2023-06-21 4 M 0 41506 A 271401 I See Footnote Restricted stock units 2023-06-21 4 M 0 41506 0 D Common Stock 41506 83014 I See Footnote Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. Securities are held in the name of Do & Rickles Investments LLC. Each restricted stock unit represents a contingent right to receive one share of the issuer's Class A common stock. The restricted stock units were granted on June 21, 2022 and vest ratably over a three-year period on each anniversary of the grant date. /s/ Cuong V Do 2023-06-21